Evidence map›Paper›PMID 32083238›Full record

ArticleJBMR plus2020

Prostate Cancer Phenotype Influences Bone Mineralization at Metastasis: A Study Using an In Vitro Prostate Cancer Metastasis Testbed.

Md Shahjahan Molla, Dinesh R Katti, Jairam Iswara, Renugopalkrishnan Venkatesan, Ramasamy Paulmurugan, Kalpana S Katti

Open access · goldAbstract read
In one paragraph

Article in JBMR plus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Nanostructured Biomaterials forCurrent opinion in biomedical engineering · 2021
    Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Md Shahjahan MollaCenter for Engineered Cancer Testbeds North Dakota State University Fargo ND USA.ORCID https://orcid.org/0000-0003-3643-2385
Dinesh R KattiCenter for Engineered Cancer Testbeds North Dakota State University Fargo ND USA.ORCID https://orcid.org/0000-0001-9866-2683
Jairam IswaraDepartment of Urology, Saint Elizabeth's Medical Center Tufts University Boston MA USA.
Renugopalkrishnan VenkatesanDepartment of Chemistry and Chemical Biology Northeastern University Boston MA USA.
Ramasamy PaulmuruganDepartment of Radiology Cellular Pathway Imaging Laboratory (CPIL), Stanford University School of Medicine Palo Alto CA USA.
Kalpana S KattiCenter for Engineered Cancer Testbeds North Dakota State University Fargo ND USA.ORCID https://orcid.org/0000-0002-1404-4018
North Dakota State University · USBoston Children's Hospital · USPalo Alto University · USScintillon Institute · USTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, two types of prostate cancer cell lines, highly metastatic PC-3 and low metastatic MDA PCa 2b (PCa) were cultured on bone mimetic scaffolds to recapitulate metastasis to bone. A unique in vitro 3D tumor model that uses a sequential culture (SC) of human mesenchymal stem cells followed by seeding with cancer cells after bone formation was initiated to study the phenotype-specific interaction between prostate cancer cells and bone microenvironment. The PCa cells were observed to be less prolific and less metastatic, and to form multicellular tumoroids in the bone microenvironment, whereas PC-3 cells were more prolific and were highly metastatic, and did not form multicellular tumoroids in the bone microenvironment. The metastatic process exhibited by these two prostate cancer cell lines showed a significant and different effect on bone mineralization and extracellular matrix formation. Excessive bone formation in the presence of PC-3 and significant osteolysis in the presence of PCa were observed, which was also indicated by osteocalcin and MMP-9 expression as measured by ELISA and qRT-PCR. The field emission scanning electron microscopy images revealed that the structure of mineralized collagen in the presence of PC-3 is different than the one observed in healthy bone. All experimental results indicated that both osteolytic and osteoblastic bone lesions can be recapitulated in our tumor testbed model and that different cancer phenotypes have a very different influence on bone at metastasis. The 3D in vitro model presented in this study provides an improved, reproducible, and controllable system that is a useful tool to elucidate osteotropism of prostate cancer cells. © 2019 The Authors.

Indexed as

BONE CELLSBONE MATRIXMATRIX MINERALIZATIONBONE MATRIXTUMOR‐INDUCED BONE DISEASECANCEROSTEOBLASTSPROSTATE CANCER; COLLAGEN

Identifiers

PMID32083238
PMCPMC7017885
OpenAlexW2991538564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.